Clinical Trials Directory

Trials / Completed

CompletedNCT02518633

Obstructive Sleep Apnoea and Adipose Tissue Dysfunction

Assessment of Hypoxia in Adipose Tissue of Subjects With Obstructive Sleep Apnoea

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Royal Devon and Exeter NHS Foundation Trust · Academic / Other
Sex
Male
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Dysfunctional adipose tissue predisposes to cardiovascular disease. Similarly, the risk of cardiovascular disease appears to be increased in subjects with obstructive sleep apnoea. Reduced adipose tissue oxygen availability has been described in obesity and may also be a mechanism in obstructive sleep apnoea. Hypoxia induces inflammation and fibrosis in adipose tissue which are factors contributing to cardiovascular risk. The investigators hypothesize that adipose tissue's oxygen uptake is reduced in subjects with obstructive sleep apnoea by comparing in vivo AT oxygenation and blood flow in tissue of control subjects.

Detailed description

Assessment includes a adipose tissue biopsy and measurement of oxygenation and blood flow by a Clarke type electrodes and non-invasive Doppler techniques.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous positive airway pressure devicesovernight use of CPAP device

Timeline

Start date
2010-03-01
Primary completion
2015-03-01
Completion
2015-11-01
First posted
2015-08-10
Last updated
2017-02-17

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02518633. Inclusion in this directory is not an endorsement.